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Abstract
Background: The present research was carried out to investigate pharmacological properties of Buxus papillosa C.K.
Schneid. (Buxaceae).
Methods: Buxus papillosa extracts of leaves (BpL), stem (BpS), roots (BpR) and BpL fractions: hexane (BpL-H),
aqueous (BpL-A) also plant constituent, cyclomicrobuxine effect were studied in jejunum, atria, aorta and tracheal
preparations from rabbit and guine-peg.
Results: Ca++ antagonistic effect of BpS, BpR, BpL-H, BpL-A and cyclomicrobuxine were conclusively suggested,
when spontaneous contractions of rabbit jejunal preparation was relaxed along with subsequent relaxation of
potassium chloride (80 mM) induced contractions. Ca++ antagonistic effect was further confirmed, when a
prominent right shift like that of verapamil was observed in Ca++ concentration-response curves, drawn in a tissue
pretreated with BpL (0.3–1.0 mg/mL). In rabbit tracheal tissues BpL, BpS, BpR, BpL-H and BpL-A produced a
prominent relaxation in contractions induced by potassium chloride (80 mM) and carbachol (1 μm). When tested in
rabbit aortic rings, BpL, BpS, BpR, BpL-H and BpL-A showed concentration-dependent (0.1–3.0 mg/mL) vasorelaxant
effect against phenylephrine (1 μM) and high K+-induced contractions. In isolated guinea-pig right atria, BpL, BpS,
BpR, BpL-H and BpL-A suppressed atrial force of spontaneous contractions, with BpL-A being most potent.
Conclusions: Our results reveal that Buxus papillosa possesses gut, airways and cardiovascular inhibitory actions.
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Background
The genus Buxus comprises of approximately 70 species
commonly called boxwood,which are native to Europe,
Asia, Africa, Madagascar, America, Maxico, Caribbean,
Cuba and China. Buxus papillosa C.K. Schneid, locally
known as shamshad is dense, compact ever green shrub
of 0.5–1.0 m height, belonging to Buxaceae family. In
Pakistan, it is distributed throughout Himalaya regions
and northern areas. Traditionally used to cure malaria,
rheumatism, skin diseases, headache, also considered
useful as antidiarrheal, antisecretorycardiotonic and
neurotonicagent [1]. It has been widelyevaluated to unfold
its phytochemical profile. Buxuspappilosa is known to
containcyclobuxupaline-C, cyclopapilosine-D, (+)-buxa-
mine-C, desoxy-16-buxidienine [2], harappamine [3],
moenjodaramine [4], papilicine [5], buxaminol-
G,cyclobuxaviridine, papilamine, papilinie [6–8], (+) -bux-
abenzamidienine, (+)-16α-acetoxybuxabenzamidienine,





none [12, 13], (E)-cyclobuxaphylamine, (Z)-cyclobuxaphy-
lamine, (+)-formylharappamine, (+)-N-formylpapalicine
[14, 15], buxatenone, cyclobuxaviramine [16], buxapapili-
nine [17], (+)papillotrienine, (+)-N(b)-demethylpapillotrie-
nine,(+)-N(b)-demethylharappamine [18], buxapapillosine
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[19], 11-hydroxybucatenone and buxahejrine [20].
Three alkaloids (Triterpenoids): buxahejramine [(20S) -
20-dimethylamino- 2′-hydroxy- 3beta-methyl-3′-methyl-
pentanoylamino-9, 10-seco-buxa-9(11), 10(19)-dien-
31-ol], buxakashmiramine [(20S)- 20-dimethylamino-
4′,6′- dimethoxy-5′- hydroxybenzoylamino- 3beta-
methyl-buxan-31-ol] and buxakashmiramine [(20S)-
20-dimethylamino-4′,6′- dimethoxy-5′- hydroxyben-
zoylamino- 3beta-methyl-buxan-31-ol] isolated from
leaves of Buxuspapillosa are reported to possess acet-
ylcholinesteraseand butyrylcholinesterase inhibitory
properties [21]. Buxus papillosa showed acaricidal ef-
fect in larval immersion test [22].
Despite of diverse ethnomedicinal and phytochem-
ical profile of this plant, extensive pharmacological
screening has not been performed yet. In our previ-
ous studies, we observed that several medicinal
plants, which exhibits similar nature of constituents
(as present in Buxus papillosa) with therapeutic po-
tential in treating ailments of gut, airways, heart and
vascular hyperactivity, usually possess spasmolytic
properties, occurred via either alone or combinations
of different pharmacodynamics mechanisms, like in-
hibition of Ca++ ingress and phosphodiesterase en-
zyme(s), antagonism of muscarinic receptors and
potassium channel activation [23–27]. In the current
investigation, the gastrointestinal, respiratory and car-
diovascular inhibitory actions of Buxus papillosa
leaves, stem and roots extracts are reported, also fur-
ther the leaves extract various fractions: hexane and
aqueous. The pure compound, isolated from leaves
ofthe plant, cyclomicrobuxine showed antispasmolytic
effect.
Methods
Plant material extraction, fractionation and isolation
Buxus papillosa was collected from Malam Jabba, Swat,
Khyber Pakhtunkhwa (KPK), Pakistan during July-
August, 2002. Specimen was authenticated by
Mahboob-ur-Rahman, taxonomist at Department of
Botany, Government Post Graduate Jahanzeb College,
Saidu Sharif, Swat, KPK. Voucher bearing number
BP-129 was obtained and specimen submitted to
herbarium at same college for future record. Plant
material was dried under shade for 20-25days and
separated into leaves (44.7 Kg), stem (14.5 Kg) and
roots (42 Kg) parts. All three parts were individually
ground and macerated in aqueous methanol (70%) for
period of 7 days at room temperature [28, 29]. Mix-
tures were then filtered and concentrated under re-
duced pressure to yieldBuxuspappilosaextracts of
leaves (BpL), stem (BpS) and roots (BpR). For defat-
ting the extract of leaves, distilled water was added
and mixed with it thoroughly, followed by mixing
with n-hex in a separating funnel. When two distinct
layers were formed the n-hexane portion was sepa-
rated out and the whole process was repeated thrice.
Finally, the entire collected n-hexane portion was
concentrated in rotary to receive (BpL-A). Similarly
for obtaining Aqueous fraction (BpL-A), the lower
layer in the separating funnel was evaporated in sep-
arate Petri dish. Cyclomicrobuxine (Fig. 1), a known
compound [30, 31] was isolated from hexane fraction
of Buxuspapillosaleaves extract, using silica gel col-
umn chromatography technique [32].
Chemicals
Acetylcholine chloride (ACh), verapamil, isoprenaline
hydrochloride, carbachol (CCh) and phenylephrine
hydrochloride (PE) were purchased from Sigma Che-
micals Co. MO, USA. Various kinds of chemical were
used for the preparation of physiological solutions
like: magnesium sulfate,sodium dihydrogen phosphate,
calcium chloride, glucose, sodium bicarbonate ,magne-
sium chloride and potassium dihydrogen phosphate
were purchased from Merck, Germany, while potas-
sium chloride (KCl), ethylenediamine tetraacetic acid
from Sigma Chemical Co, USA. Similarly Sodium
chloride was purchased from BDH Laboratory,
England. Analytical grade chemical were used for per-
forming the experiments.
Animals
For conducting this study Adult guinea-pigs (500–
550 g) and rabbits (1–1.2 kg) were collected from the
Animal House of Aga Khan University. Standard diet
and water were given to all of them under maintained
temperature of 23–25 °C. Rabbits and guinea-pigs
were starved for 24 h before starting the experiments
Fig. 1 Chemical structure of cyclomicrobuxine, pure compound
isolated from leaves of Buxus papillosa
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and were scarified by cervical dislocation to obtain
the target tissue. Studies conducted completely com-
ply with the protocols of the Institute of Laboratory
Animal Resources, Commission on Life Sciences,
National Research Council [33], approved by Research
and Ethics Committee (Ref#: REC/RIPS/2016/005),
Riphah Institute of Pharmaceutical Sciences.
Rabbit jejunum
Three segments of jejunum, each 2 cm were dissected
out from rabbit abdomen. Single segment of jejunum
was suspended via a thread in a tissue bath continu-
ously supplied with carbogen. Tyrode’s solution used
is composed of (mM): NaHCO3 11.90, glucose 5.55,
CaCl2 1.8, KCl 2.68, MgCl2 1.05, NaCl 136.9 and
NaH2PO4 0.42. Bioscience transducers and Harvard
oscillograph was used for recording intestinal re-
sponses isotonically. Before addition of drug, tissue
was freely permitted to equilibrate for 30 min. The
tissue was then completely stabilized by applying sub-
maximal concentration of 0.3 μM Ach after every
three minutes, unless uniform responses were
achieved. Spontaneous contractions are exhibited in
such environment, thereby providing an opportunity
to directly check the spasmolytic effect, without prior
applying of agonist [34]. Depolarization of jejunal
preparations was done by high K+ (80 mM), so that
Ca++ channel blockade (CCB) activity can be deter-
mined according to procedure of Gilani et al. [35].
After sustained contractions produced by high K+ in
jejunal tissue, test substance was applied for produ-
cing inhibitory effect. For confirming the Ca++ antag-
onistic activity, the jejunal tissue was stabilized in
normal and Ca++-free Tyrode’s solutions. After
30 min the tissue was washed with by K+-rich and Ca
++-free Tyrode’s solution. CRCs of Ca++ were drawn
and recorded. The treated tissue was applied with test
substance and incubated for one hour, followed by re-
construction of CRCs of Ca++ to explore the possible
CCB effect. Different concentration of test substance
was applied on treated tissue and CRCs of Ca++ were
constructed.
Rabbit trachea
Soon after dissection of trachea, approximately 2–
3 mm wide tracheal tube rings were cut down, each
ring containing two cartilages were opened further by
longitudinal incision to prepare tracheal strips [36].
Single tracheal strip was suspended in tissue bath
(20 mL) containing standard physiological kreb’s solu-
tion, continuously supplied with carbogen and main-
tained at 37 °C (pH 7.4). Kreb’s solution used for this
experiment was composed of (mM) glucose: 11.7,
KH2PO4: 1.2, NaCl: 118.2, CaCl2: 2.5, MgSO4. 7H2O:
1.2, NaHCO3: 25.0, KCl: 4.7. Strips were permitted to
equilibrate for almost 1 h before applying any test sub-
stance. Throughout experiment tracheal strips were ap-
plied with tension of 1 g. After the application of
spasmogens like CCh and/or high K+, when sustained
contractions were achieved then spasmolytic effect of drug
was tested by its addition in cumulative manner. Grass
model 7 Polygraph (USA) was used for recording the iso-
metric responses of tracheal strips.
Rabbit aorta
Krebs solution in a 20 mL tissue bath was used for con-
ducting the experiment; aortic rings were mounted in it,
where bath environment was maintained at 37 °C along
with continuous supply of carbogen. Before studying the
effect of drug, aortic ring was stabilized by applying ten-
sion of 2 g. After the application of PE (1 μM) and K+
(80 mM), vasorelaxant effect of testing material was
assessed [37]. Force-displacement transducer and Grass
model 7 Polygraph were used for recording changes in
isometric tension of aortic rings.
Guinea-pig atria
Right atrium was isolated and suspended through wire
gauze in 20 mL tissue bath containing Krebs solute,
maintained at 32 °C continuously supplied with carbo-
gen gas. Due to presence of natural pacemaker in the
atrium, Spontaneous beating was observed under the
resting tension of 1 g [38]. After 45 min of equilibrium
period, control response curves of 1 μM, isoprenaline
and ACh were recorded. Force-displacement transducer
and Grass model 7 Polygraph were used for recording
changes in isometric tension of atria.
Statistical analysis
Recorded data obtained is shown as mean ± standard
error of mean (SEM, n = number of experiment) and
median effective concentrations (EC50) with 95% confi-
dence intervals (CI). GraphPad program (USA) was used




Isolated jejunal preparations spontaneous contractions
and induced contractions of high K+ (80 mM) were con-
centration dependently inhibited by BpL, BpS, BpR,
BpL-H and BpL-A with respective EC50 values of 0.63
(0.46–0.86, n = 5, 95% CI) and 0.80 (0.71–0.84, n = 6),
1.02 (0.70–1.50, n = 5) and 1.20 (0.85–1.65, n = 4), 1.25
(0.99–1.65, n = 6) and 1.23 (0.94–1.54, n = 5), 0.55 (0.42–
0.74, n = 3) and 0.73 (0.62–0.89, n = 3), 0.014 (0.008–
0.02, n = 6) and 0.008 mg/mL (0.001–0.04, n = 4) as
shown in Figs. 2, 3 and Table 1. Cyclomicrobuxine
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Fig. 2 Concentration-dependent inhibitory effect of Buxus papillosa
different parts extracts: a leaves (BpL), b stem (BpS) and c roots
(BpR) on spontaneous and high K+-induced contractions in isolated
rabbit jejunum preparations. Values shown are mean ± SEM, n = 4–6
Fig. 3 Concentration-dependent inhibitory effect of Buxus papillosa
leaves extract fractions: a hexane (BpL-H) and b aqueous (BpL-A) on
spontaneous and high K+-induced contractions in isolated rabbit
jejunum preparations. Values shown are mean ± SEM, n = 3–6
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relaxed spontaneous contractions and induced contrac-
tions of high K+ (80 mM) with EC50 values of 21.0
(10.1–30.3, n = 2) and 65.1 μg/mL (50.1–70.6, n = 2) re-
spectively (Fig. 4a). Verapamil relaxed spontaneous and
potassium chloride (80 mM)-induced contractions
(Fig. 4b) with respective EC50 values of 0.09 (0.07–0.11,
n = 4) and 0.013 μM (0.01–0.02, n = 4). BpL (0.3–
1.0 mg/mL) shifted Ca++ CRCs to the right (Fig. 5a), like
that caused by verapamil (Fig. 5b).
Effect on trachea
Pre-contracted, tracheal preparations with CCh (1 μM)
and K+ (80 mM) were concentration-dependently re-
laxed by BpL, BpS, BpR, BpL-H and BpL-A with EC50
values of 0.28 (0.24–0.33, n = 5) and 0.28 (0.22–0.36, n =
4), 0.26 (0.13–0.41, n = 4) and 0.85 (0.70–0.94, n = 4),
0.10 (0.07–0.13, n = 4) and 0.34 (0.23–0.59, n = 4), 0.25
(0.16–0.33, n = 2) and 0.31 (0.27–0.37, n = 2), 0.12 (0.08–
0.19, n = 2) and 0.10 mg/mL (0.04–0.25, n = 3) respect-
ively (Figs. 6, 7 and Table 1).
Effect on aorta
When tested against induced contractions of potassium
chloride (80 mM) and PE (1 μM), BpL, BpS, BpR, BpL-
H and BpL-A exhibited vasorelaxant effect (Figs. 8, 9
and Table 1) with respective EC50 values of 0.75 (0.50–
1.1, n = 4) and 0.50 (0.40–0.60, n = 5), 0.98 (0.70–1.41, n
= 4) and 1.3 (1.0–1.50, n = 4), 1.25 (0.91–1.61, n = 4) and
0.95 (0.81–1.11, n = 4), 0.98 (0.96–1.0, n = 3) and 1.1
(0.92–1.3, n = 2), 0.40 (0.23–0.71, n = 2) and 0.37 mg/mL
(0.16–0.89, n = 2).
Effect on atria
BpL, BpS, BpR, BpL-H and BpL-A exerted
concentration-dependent inhibitory effect on spontan-
eously beating atrial force of contractions with EC50
values of 4.0 (3.0–5.5, n = 3), 1.80 (0.25–6.30, n = 3), 3.60
(3.50–4.0, n = 3), 1.50 (0.44–4.0, n = 3) and 0.30 mg/mL
(0.28–0.35, n = 3) respectively (Fig. 10 and Table 1).
Discussion
When tested in jejunum preparations, Buxus papillosa
different parts extracts and fractions exhibited antispas-
modic effect through inhibition of spontaneous contrac-
tions. Antispasmodic effect of aqueous fraction was 45
and 40 times more potent as compared to parent leaves
extract and hexane fraction respectively. The plant iso-
lated compound, cyclomicrobuxine also relaxed jejunum
spontaneous contractions. When the level of free [Ca++]
increases the rudiments responsible for contractions in
the cells get activated, leading to ultimate contraction of
smooth muscles [39, 40]. Intracellular calcium level ei-
ther increases through voltage dependent L-type Ca++
channels (VDCs) or through discharge from sarcoplas-
mic reticulum internal stores. Regulation of Spontaneous
intestinal contractions is primarily attributed to intermit-
tent depolarization and action potential appears at the
height of depolarization when rapid influx of Ca++ via
VDCs takes place [41]. So the spontaneous intestinal
contractions may be inhibited by the plant extract due
to interruption with Ca++ release inside the cell or Ca++
influx through VDCs.
Previous studies strongly suggest that plant extracts
usually mediate relaxation through blockade of Ca++
channels [42–46]. To check out whether same mechan-
ism is followed by this plant extract for achieving spas-
molytic effect, Buxus papillosa test samples were
screened against contractions induced by potassium
chloride (80 mM) which was fully inhibited, with
Aqueous fraction being most potent. Plant bioactive
constituent, cyclomicrobuxine also relaxed contractions
induced by potassium chloride (80 mM). It was observed
that, cyclomicrobuxine was 30 and 12 times more potent
respectively in comparison to plant extracts, against
spontaneous and potassium chloride induced contrac-
tions. Verapamil, a standard Ca++ channel blocker [47]
also inhibited spontaneous contractions and contractions
induced by potassium chloride (80 mM) non-specifically.
Smooth muscle contraction is induced by high concen-
tration of K+ (>30 mM) via opening of VDCs, where it
permits entrance of Ca++ from outside the cell [48]. So,
drug inhibiting potassium chloride (80 mM) induced
Table 1 Comparative median effective concentration (EC50) values of the Buxus papillosa different parts extracts: leaves (BpL), stem
(BpS) and roots (BpR) also leaves extract fractions: hexane (BpL-H) and aqueous (BpL-A) against various parameters in different
isolated tissue preparations of rabbit and guinea-pig (atria)
Sample Jejunum Trachea Aorta Atria
Spontaneous K+ (80 mM) CCh (1 μM) K+ (80 mM) PE (1 μM) K+ (80 mM) Atrial force
BpL 0.63 0.80 0.28 0.28 0.75 0.50 4.0
BpS 1.02 1.20 0.26 0.85 0.98 1.3 1.80
BpR 1.25 1.23 0.10 0.34 1.25 0.95 3.60
BpL-H 0.55 0.73 0.25 0.31 0.98 1.1 1.50
BpL-A 0.014 0.008 0.12 0.10 0.40 0.37 0.30
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contractions is believed to be the inhibitor of Ca++ influx
[49]. When plant extract exhibited right shift in the Ca++
CRCs and suppressed the maximal response like that of
a standard calcium antagonist; verapamil, the existence
of Ca++ antagonist effect strengthened. Concentration-
dependent inhibition of slow entry of Ca++ is one of the
prominent and common features of calcium antagonists
[50, 51]. Buxus papillosa has been medicinally used in
gut hyper motility disorder and diarrhea. Ca++ channel
blockers are usually effective in this condition [52] and
the observed CCB effect of this plant may clarify its po-
tential in these diseases.
In trachea, Buxus papillosa test samples relaxed the
contractions induced by high K+ and CCh, showing
tracheo-relaxant effect. Smooth muscles contractions is
produced by cholinergic agonist like CCh and high K+
via stimulation of muscarinic receptor and opening of L-
type Ca++ channel respectively, finally enhancing Ca++
level inside the cell and bronco constriction as the
Fig. 5 Concentration-response curves of Ca++ in absence and
presence of increasing concentrations of a Buxus papillosa leaves
extract (BpL) and b verapamil in isolated rabbit jejunum
preparations. Values shown are mean ± SEM, n = 3–4
Fig. 4 Concentration-dependent inhibitory effect of a
cyclomicrobuxine, a constituent of Buxux papillosa and b verapamil
on spontaneous and high K+-induced contractions in isolated rabbit
jejunum preparations. Values shown are mean ± SEM, n = 2–4
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Fig. 7 Concentration-dependent inhibitory effect of Buxus papillosa
leaves extract fractions: a hexane (BpL-H) and b aqueous (BpL-A) on
carbachol (CCh) and high K+-induced contractions in isolated rabbit
tracheal preparations. Values shown are mean ± SEM, n = 2–3
Fig. 6 Concentration-dependent inhibitory effect of Buxus papillosa
different parts extracts: a leaves (BpL), b stem (BpS) and c roots
(BpR) on carbachol (CCh) and high K+-induced contractions in
isolated rabbit tracheal preparations. Values shown are
mean ± SEM, n = 4–5
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Fig. 8 Concentration-dependent inhibitory effect of Buxus papillosa
different parts extracts: a leaves (BpL), b stem (BpS) and c roots
(BpR) on phenylephrine (PE) and high K+-induced contractions in
isolated rabbit aortic preparations. Values shown are
mean ± SEM, n = 4–5
Fig. 9 Concentration-dependent inhibitory effect of Buxus papillosa
leaves extract fractions: a hexane (BpL-H) and b aqueous (BpL-A) on
phenylephrine (PE) and high K+-induced contractions in isolated
rabbit aortic preparations. Values shown are mean ± SEM, n = 2–3
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ultimate result [53]. Non-specific inhibition of two spas-
mogens by the plant extract suggest nonspecific bronch-
odilatory effect, probably mediated through calcium
channel blockade mechanism. For relieving symptoms of
congestive respiratory disorders Ca++ antagonists are ef-
ficient [54] and existence of CCB activity in Buxus papil-
losa as revealed by this study may provide basis for this
plant as an effective agent for treating asthma.
The plant Buxuspapillosa was also studied in vascular
and heart tissues for possible cardio-depressent and vasor-
elaxant actions, due to well known efficacy of Ca++ antago-
nists in cardiovascular disorders, such as hypertension
[55, 56]. When applied on isolated aorta preparations,
Buxus papillosa material inhibited contractions produced
by high K+ and PE. Vascular contraction is induced by PE
via increase in cytosolic Ca++, to a degree because of Ca++
entry via receptor operated channels and up to some ex-
tent due to Ca++ release from intracellular stores [57].
Non-specific inhibition of high K+ and PE by the plant ex-
tract suggests nonspecific vasodilatory effect, probably me-
diated via CCB mechanism. The product of cardiac output
and vascular resistance results blood pressure [58], so the
likely inhibitory effect of this extract on heart was studied.
Atrial force of contractions was inhibited by Buxus papil-
losa in spontaneously beating atria of guinea-peg.
Among all tested samples of the plant, aqueous fraction
most potently caused cardiac depression, being 13 times
more potent than parent extract. Cardiac inhibitory effect
of Buxus papillosa, occurred possibly via CCB pathway
(observed in gut, trachea and vascular tissues experi-
ments), as Ca++ antagonists reportedly possess negative
inotropic and chronotropic effects [59]. All tested samples
of Buxus papillosa (except aqueous fraction, which was
about 10 times more potent in relaxing intestinal prepara-
tions than tracheal) were relatively more powerful spas-
molytic in airways, in comparison to other targeted
tissues, this might be due to heterogenicity of Ca++ chan-
nels, as known to be heterogeneous [60, 61]. Various types
of Ca++ channels blockers, for different organ system are
reported to demonstrate selectivity [62, 63]. For instance,
nifedipine reportedly is a vascular selective, as compared
to heart [64]. On the other hand, there is also the possibil-
ity of phosphodiestarse inhibitors (PDEIs)-like constitu-
ent(s), which have impaired cardiac inhibitory potency.
Fig. 10 Concentration-dependent inhibitory effect of Buxus papillosa different parts extracts: a leaves (BpL), b stem (BpS) and c roots (BpR) also
leaves extract fractions: d hexane (BpL-H) and e aqueous (BpL-A) on force of contraction of the spontaneously beating isolated guinea-pig right
atrial preparations. Values shown are mean ± SEM, n = 3
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We have reported co-existence of PDEIs component(s)
with Ca++ antagonist(s) in some medicinal plants [65–68].
As, combination of PDEIs and Ca++ antagonists have syn-
ergistic spasmolytic interaction in smooth muscles (more
effective in respiratory system) and opposing/side effects
neutralizing effects in heart [69], hence might making the
plant more efficacious to relax airways, compared to car-
diac muscles.
Conclusions
These results reveal that Buxus papillosa possesses anti-
spasmodic, bronchodilatory, vasodilator and cardiac inhibi-
tory effects. Thus, this study provides scientific evidence
for its potential therapeutic application in hyperactive
gastrointestinal, respiratory and cardiovascular disorders.
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